• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安哥拉罗安达和卡宾达地区HIV-1以及HIV-2/HTLV-IV感染的流行情况。

Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola.

作者信息

Böttiger B, Palme I B, da Costa J L, Dias L F, Biberfeld G

机构信息

Department of Immunology, National Bacteriological Laboratory, Stockholm, Sweden.

出版信息

J Acquir Immune Defic Syndr (1988). 1988;1(1):8-12.

PMID:2905739
Abstract

A seroepidemiological study of human immune deficiency virus type 1 (HIV-1) and HIV-2/human T-lymphotropic virus type IV (HIV-2/HTLV-IV) infections was performed in Angola in October 1986. Until then five cases of acquired immune deficiency syndrome (AIDS) had been registered in Angola. During this study, another three cases with clinical AIDS were found and confirmed by HIV-1 serology. A total of 1,215 sera from groups of healthy persons and patients were tested for HIV-1 and HIV-2/HTLV-IV antibodies by enzyme-linked immunosorbent assays (ELISA). Sera positive by ELISA were also tested by Western blot (WB) analysis. In Luanda, the capital, HIV-1 antibodies were demonstrated in 0.4% (2/452) of male blood donors, in 0.3% (1/357) of pregnant women, in 1% (1/100) of tuberculosis patients, in 4% (4/94) of patients at medical wards, and in none of 22 women hospitalized with pelvic infections. In the Cabinda province, 11% (4/38) of postnatal women at a maternity ward were found to be HIV-1 seropositive, but only 2% (1/55) of other hospitalized patients and none of 32 male blood donors or 59 healthy persons in a village on the border to Zaire. Specific antibodies to HIV-2/HTLV-IV were not found in any of the sera. However, 16 out of 17 HIV-1 positive sera cross-reacted with HIV-2/HTLV-IV core proteins by WB. In October 1987, 280 of the blood donors from Luanda were retested for HIV-1 antibodies and one of them was found to have seroconverted during the previous year.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1986年10月在安哥拉进行了一项关于1型人类免疫缺陷病毒(HIV-1)和HIV-2/人类嗜T淋巴细胞病毒IV型(HIV-2/HTLV-IV)感染的血清流行病学研究。在此之前,安哥拉已登记了5例获得性免疫缺陷综合征(AIDS)病例。在这项研究期间,又发现了另外3例临床AIDS病例,并通过HIV-1血清学得到证实。通过酶联免疫吸附测定(ELISA)对来自健康人群和患者组的1215份血清进行了HIV-1和HIV-2/HTLV-IV抗体检测。ELISA检测呈阳性的血清也通过免疫印迹(WB)分析进行了检测。在首都罗安达,0.4%(2/452)的男性献血者、0.3%(1/357)的孕妇、1%(1/100)的结核病患者、4%(4/94)的内科病房患者以及22例因盆腔感染住院的女性中均检测到HIV-1抗体。在卡宾达省,一家产科病房11%(4/38)的产后妇女被发现HIV-1血清学呈阳性,但在其他住院患者中只有2%(1/55)呈阳性,在与扎伊尔接壤边境的一个村庄的32名男性献血者和59名健康人中均未检测到。在任何一份血清中均未发现针对HIV-2/HTLV-IV的特异性抗体。然而,17份HIV-1阳性血清中有16份通过WB与HIV-2/HTLV-IV核心蛋白发生交叉反应。1987年10月,对来自罗安达的280名献血者重新检测了HIV-1抗体,其中1人在前一年血清发生了转化。(摘要截选至250词)

相似文献

1
Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola.安哥拉罗安达和卡宾达地区HIV-1以及HIV-2/HTLV-IV感染的流行情况。
J Acquir Immune Defic Syndr (1988). 1988;1(1):8-12.
2
A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection.安哥拉共和国六个省份的HIV-1和HIV-2血清流行率研究:HIV感染传播的线索
J Acquir Immune Defic Syndr (1988). 1990;3(8):780-6.
3
Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.尼日利亚伊巴丹孕妇血清中与1型和2型人类免疫缺陷病毒以及I型和II型人类嗜T淋巴细胞病毒血清学交叉反应的证据。
Int J Epidemiol. 1995 Feb;24(1):198-203. doi: 10.1093/ije/24.1.198.
4
Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients.
Eur J Epidemiol. 1990 Jun;6(2):201-6. doi: 10.1007/BF00145794.
5
HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.艾滋病毒和人类嗜T淋巴细胞病毒I型抗体研究:20世纪60年代的孕妇、艾滋病患者、同性恋者以及患有热带痉挛性截瘫的个体。
Yale J Biol Med. 1987 Nov-Dec;60(6):569-74.
6
Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.安哥拉罗安达匿名艾滋病毒检测人群中人类免疫缺陷病毒、丙型肝炎病毒、乙型肝炎病毒和梅毒螺旋体的流行情况。
S Afr Med J. 2013 Jan 24;103(3):186-8. doi: 10.7196/samj.6097.
7
Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.1993 - 1994年巴西塞阿拉州福塔莱萨市HIV - 1、HIV - 2和HTLV抗体的流行情况。
Int J STD AIDS. 1996 Aug-Sep;7(5):365-9. doi: 10.1258/0956462961918103.
8
Serological survey of human immunodeficiency virus (HIV) in Ethiopia.埃塞俄比亚人类免疫缺陷病毒(HIV)血清学调查
J Med Virol. 1989 May;28(1):21-4. doi: 10.1002/jmv.1890280106.
9
Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area.人嗜T淋巴细胞病毒I型(HTLV-I)与人类免疫缺陷病毒1型(HIV-1)的合并感染:华盛顿特区地区IgG和IgM抗体的流行情况
Eur J Epidemiol. 1988 Dec;4(4):426-34. doi: 10.1007/BF00146393.
10
HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.意大利北部艾滋病患者以及有感染艾滋病风险的HIV-1血清阳性和血清阴性个体中HTLV-1的血清流行率。
Eur J Epidemiol. 1989 Mar;5(1):37-41. doi: 10.1007/BF00145042.

引用本文的文献

1
Transmission modes and the evolution of virulence : With special reference to cholera, influenza, and AIDS.传播模式与毒力演变:特别参考霍乱、流感和艾滋病。
Hum Nat. 1991 Mar;2(1):1-30. doi: 10.1007/BF02692179.
2
Prevalence of antibodies to HIV-1 and HIV-2 in women attending a sexually transmitted disease clinic in Luanda, Angola.安哥拉罗安达一家性传播疾病诊所女性中抗HIV-1和抗HIV-2抗体的流行情况。
Genitourin Med. 1995 Dec;71(6):413-4. doi: 10.1136/sti.71.6.413.
3
Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2.
用于检测抗2型人类免疫缺陷病毒抗体的免疫荧光测定法。
J Clin Microbiol. 1989 Nov;27(11):2502-4. doi: 10.1128/jcm.27.11.2502-2504.1989.
4
Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.通过不同血清学方法检测到的1型和2型人类免疫缺陷病毒之间的包膜交叉反应性:交叉中和与针对主要中和位点的反应性之间的相关性
J Virol. 1990 Jul;64(7):3492-9. doi: 10.1128/JVI.64.7.3492-3499.1990.